| Catalog Number |
06L22-25 |
| Medical Device Problem Code |
Low Test Results (2458)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
08/24/2017
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
| |
|
Event or Problem Description
|
|
The customer is requesting an explanation for why the architect total anti-hbcore is nonreactive on a patient, but the architect anti-hbcore igm is reactive.The results provided were: anti-hbcore-m =1.62s/co (>/=1.21s/co = reactive); ausab = >1000.There was no reported impact to patient management.There was no additional patient information provided.
|
| |
|
Additional Manufacturer Narrative
|
|
Potential false non-reactive results for one patient sample when using architect core reagent, list number 6l22-25, lot number 74196li00 compared to reactive core-m results.A review of tickets determined that there is normal complaint activity for lot number 74196li00 and no trends were identified for the complaint issue.Sensitivity testing was performed with a retained kit of lot 74196li00 by testing two commercially available seroconversion panels (biomex scp-hbv-001 and 004).The lot detected the same bleeds of the seroconversion panels as reactive with comparable s/co values.Manufacturing documentation of lot 74196li00 has been reviewed and no contributing factors to the complaint could be identified.A review of labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for architect core reagent, list number 6l22-25, lot number 74196li00.
|
| |
|
Additional Manufacturer Narrative
|
|
Suspect medical device; lot# from unknown to 74196li00.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
| |
|
Additional Manufacturer Narrative
|
|
Suspect medical device: brand name from anti-hbc to architect core; and common device name from architect core to anti-hbc.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
| |
|
Search Alerts/Recalls
|